financetom
Business
financetom
/
Business
/
Gilead Sciences Insider Sold Shares Worth $6,590,487, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilead Sciences Insider Sold Shares Worth $6,590,487, According to a Recent SEC Filing
Nov 14, 2025 12:48 AM

03:37 AM EST, 11/14/2025 (MT Newswires) -- Deborah H Telman, Executive Vice President of Corporate Affairs and General Counsel, on November 12, 2025, sold 53,646 shares in Gilead Sciences ( GILD ) for $6,590,487. Following the Form 4 filing with the SEC, Telman has control over a total of 43,676 common shares of the company, with 43,676 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/xslF345X05/wk-form4_1763080568.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet Unusual Options Activity For August 07
Alphabet Unusual Options Activity For August 07
Aug 7, 2024
Deep-pocketed investors have adopted a bullish approach towards Alphabet , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GOOGL usually suggests something big is about to happen. We gleaned this information from our observations today...
Ocular Therapeutix's Shares Rise After Higher Q2 Revenue That Beat Forecast
Ocular Therapeutix's Shares Rise After Higher Q2 Revenue That Beat Forecast
Aug 7, 2024
10:12 AM EDT, 08/07/2024 (MT Newswires) -- Ocular Therapeutix ( OCUL ) shares rose 4.3% in recent Wednesday trading after the biopharmaceutical company posted higher Q2 net revenue from a year earlier that also topped analysts' forecasts. The company reported a Q2 net loss of $0.26 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected...
Advantage Solutions Q2 Net Loss Widens, Revenue Falls
Advantage Solutions Q2 Net Loss Widens, Revenue Falls
Aug 7, 2024
10:09 AM EDT, 08/07/2024 (MT Newswires) -- Advantage Solutions ( ADV ) on Wednesday reported a Q2 net loss of $0.31 per diluted share compared with a $0.03 loss a year earlier. The lone analyst polled by Capital IQ expected a $0.24 loss. Revenue for the quarter ended June 30 was $873.4 million, compared with $963.8 million a year earlier....
--Deutsche Bank Adjusts Target on Fidelity National Information Services to $73 From $70, Hold Rating Maintained
--Deutsche Bank Adjusts Target on Fidelity National Information Services to $73 From $70, Hold Rating Maintained
Aug 7, 2024
10:12 AM EDT, 08/07/2024 (MT Newswires) -- Price: 76.81, Change: +0.27, Percent Change: +0.35 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved